Mexico - Delayed Quote • MXN
Cassava Sciences, Inc. (SAVA.MX)
At close: February 12 at 2:22 PM CST
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in MXN.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Remi Barbier | Founder, Chairman, President & CEO | 20.63M | 10.31M | 1960 |
| Mr. Eric J. Schoen | Chief Financial Officer | 7.92M | -- | 1968 |
| Mr. R. Christopher Cook | Senior VP, Company Secretary & General Counsel | 7.32M | -- | 1964 |
| Dr. James W. Kupiec M.D. | Chief Medical Officer | 7.49M | -- | 1953 |
| Dr. George Thornton Ph.D. | Senior Vice President of Technology | -- | -- | -- |
| Mr. Michael Zamloot | Senior Vice President of Technical Operations | -- | -- | -- |
| Dr. Michael Marsman Pharm.D. | Senior Vice President of Regulatory Affairs | -- | -- | -- |
| Dr. Lindsay H. Burns Ph.D. | Senior Vice President of Neuroscience | -- | -- | -- |
Cassava Sciences, Inc.
6801 N. Capital of Texas Highway
Suite 300 Building 1
Austin, TX 78731
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 29
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.
Corporate Governance
Cassava Sciences, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 9. The pillar scores are Audit: 10; Board: 10; Shareholder Rights: 8; Compensation: 8.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
Apr 29, 2024 - May 03, 2024
Cassava Sciences, Inc. Earnings Call
Related Tickers
VRPX Virpax Pharmaceuticals, Inc.
3.1000
+8.01%
ASLN ASLAN Pharmaceuticals Limited
0.4153
-7.30%
ADTX Aditxt, Inc.
2.3900
-5.53%
EQ Equillium, Inc.
1.7100
-5.52%
NRXP NRx Pharmaceuticals, Inc.
3.5400
+12.74%
RAPT RAPT Therapeutics, Inc.
8.10
+3.85%
MDGL Madrigal Pharmaceuticals, Inc.
193.33
-0.54%
VRTX Vertex Pharmaceuticals Incorporated
397.48
-0.06%
IOVA Iovance Biotherapeutics, Inc.
11.64
+0.87%